BlackRock Investment Management’s MacroGenics MGNX Stock Holding History

BlackRock Investment Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.54M	Sell	124,466 -430	-0.3%	-$10.8K	﹤0.01%	2059
2016 Q3	$3.74M	Buy	124,896 +211	+0.2%	+$6.28K	﹤0.01%	1690
2016 Q2	$3.37M	Buy	124,685 +11,609	+10%	+$262K	﹤0.01%	1719
2016 Q1	$2.12M	Buy	113,076 +1,835	+2%	+$34.9K	﹤0.01%	1960
2015 Q4	$3.44M	Buy	111,241 +540	+0.5%	+$16.4K	﹤0.01%	1664
2015 Q3	$2.37M	Buy	110,701 +10,785	+11%	+$338K	﹤0.01%	1949
2015 Q2	$3.79M	Buy	99,916 +41,587	+71%	+$1.37M	﹤0.01%	1720
2015 Q1	$1.83M	Buy	58,329 +726	+1%	+$24.6K	﹤0.01%	2093
2014 Q4	$2.02M	Sell	57,603 -822	-1%	-$20.5K	﹤0.01%	2032
2014 Q3	$1.22M	Buy	58,425 +1,004	+2%	+$20.8K	﹤0.01%	2376
2014 Q2	$1.25M	Buy	57,421 +39,520	+221%	+$831K	﹤0.01%	2446
2014 Q1	$498K	Buy	17,901 +2,814	+19%	+$99.4K	﹤0.01%	2955
2013 Q4	$414K	Buy	+15,087	New	+$395K	﹤0.01%	3037

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Investment Management's MGNX Position: Q4 2016 in Review

BlackRock Investment Management reduced its MacroGenics (MGNX) stake by 0.34% in Q4 2016, selling an estimated $10.8K and leaving 124,466 shares worth $2.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2059.

BlackRock Investment Management first reported a position in MGNX in Q4 2013 and has held it in 13 quarters since. The position peaked at $3.79M in Q2 2015. 131 funds tracked by Wall St. Rank hold MGNX as of Q4 2016.

BlackRock Investment Management held 124,466 shares of MacroGenics worth $2.54M as of Q4 2016.
BlackRock Investment Management sold 430 MacroGenics shares in Q4 2016, an estimated $10.8K.
MacroGenics made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2059 holding.
BlackRock Investment Management first reported a position in MacroGenics in Q4 2013 and has held it in 13 quarters since.
BlackRock Investment Management's MacroGenics position peaked at $3.79M in Q2 2015.
131 funds tracked by Wall St. Rank held MacroGenics as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.